Document reference

2017/2710(DEA)  
Principles of and guidelines for good manufacturing practice for investigational medicinal products for human use and arrangements for inspections  
Basic information  

2017/2710(DEA)

DEA - Delegated acts procedure

Supplementing 2012/0192(COD)

Subject
4.20.04 Pharmaceutical products and industry

Status

Procedure completed - delegated act enters into force

 

Key players  
  • Committee responsible
    Rapporteur
    Appointed
    ENVI  
    Environment, Public Health and Food Safety
Key events  
23/05/2017
Non-legislative basic document published
23/05/2017
Initial period for examining delegated act 2 month(s)
31/05/2017
Committee referral announced in Parliament, 1st reading/single reading
17/07/2017
Delegated act not objected by Council
01/08/2017
Delegated act not objected by Parliament
Technical information  
Procedure reference
2017/2710(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
ENVI/8/10003
Documentation gateway  
What do you think of the Legislative Observatory?  
If you can spare a couple of minutes to complete our anonymous survey we would be very happy. Your answers will help us to provide you with an even better service and user experience.


  Do not show this message again